Comment from Cruelty Free International

Summary: Cruelty Free International supports the proposed guidance but urges the FDA to explicitly emphasize and include examples of AI applications that can replace, rather than just reduce, animal testing. They argue that prioritizing human-relevant data and modern AI models will improve drug development outcomes, reduce costs, and align with ethical standards.